[HTML][HTML] The nephrologist's guide to cannabis and cannabinoids
JL Rein - Current Opinion in Nephrology and Hypertension, 2020 - journals.lww.com
The nephrologist's guide to cannabis and cannabinoids : Current Opinion in Nephrology and
Hypertension The nephrologist's guide to cannabis and cannabinoids : Current Opinion in …
Hypertension The nephrologist's guide to cannabis and cannabinoids : Current Opinion in …
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
PE Stevens, SB Ahmed, JJ Carrero… - Kidney …, 2024 - kidney-international.org
This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …
Pharmacological data science perspective on fatal incidents of morphine treatment
Y Noufal, D Kringel, SW Toennes, R Dudziak… - Pharmacology & …, 2023 - Elsevier
Morphine prescribed for analgesia has caused drug-related deaths at an estimated
incidence of 0.3% to 4%. Morphine has pharmacological properties that make it particularly …
incidence of 0.3% to 4%. Morphine has pharmacological properties that make it particularly …
Analgesic use in patients with advanced chronic kidney disease: a systematic review and meta-analysis
SN Davison, S Rathwell, C George… - … Journal of Kidney …, 2020 - journals.sagepub.com
Background: Pain is common in patients with chronic kidney disease (CKD). Analgesics may
be appropriate for some CKD patients. Objectives: To determine the prevalence of overall …
be appropriate for some CKD patients. Objectives: To determine the prevalence of overall …
Drug safety in episodic migraine management in adults part 1: acute treatments
YY Orlova, S Mehla, AL Chua - Current Pain and Headache Reports, 2022 - Springer
Abstract Purpose of Review The aim of this review is to aid in choosing safe options when
assessing potential risks of acute migraine treatments based on known mechanisms of …
assessing potential risks of acute migraine treatments based on known mechanisms of …
[HTML][HTML] Analgesic use and associated adverse events in patients with chronic kidney disease: a systematic review and meta-analysis
E Lambourg, L Colvin, G Guthrie, H Walker… - British Journal of …, 2022 - Elsevier
Background Treating pain in the context of chronic kidney disease (CKD) is challenging
because of altered pharmacokinetics and pharmacodynamics, with an increased risk of …
because of altered pharmacokinetics and pharmacodynamics, with an increased risk of …
Drug stewardship in chronic kidney disease to achieve effective and safe medication use
RK Hall, R Kazancıoğlu, T Thanachayanont… - Nature Reviews …, 2024 - nature.com
People living with chronic kidney disease (CKD) often experience multimorbidity and require
polypharmacy. Kidney dysfunction can also alter the pharmacokinetics and …
polypharmacy. Kidney dysfunction can also alter the pharmacokinetics and …
[HTML][HTML] Frailty modifies the association between opioid use and mortality in chronic kidney disease patients with diabetes: a population-based cohort study
The prevalence of chronic pain in patients with chronic kidney disease (CKD) and diabetes
mellitus is high and correlates with higher frailty risk, but satisfactory pain control frequently …
mellitus is high and correlates with higher frailty risk, but satisfactory pain control frequently …
A drug utilization and drug interaction study in renal transplant patients: Implications for an urgent need for drug deprescribing
K Sridharan, S Shah, O Al Segai… - … Journal of Risk & …, 2023 - content.iospress.com
BACKGROUND: Renal transplant patients receive several drugs concomitantly.
OBJECTIVE: Limited literature exists evaluating the drug use in this population that is at high …
OBJECTIVE: Limited literature exists evaluating the drug use in this population that is at high …
Effect of renin-angiotensin system inhibitors on the comparative nephrotoxicity of NSAIDs and opioids during hospitalization
Background Nonsteroidal anti-inflammatory drugs (NSAIDS) are increasingly important
alternatives to opioids for analgesia during hospitalization as health systems implement …
alternatives to opioids for analgesia during hospitalization as health systems implement …